DFTX FY 2018 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$6,681

Operating Income

-$861,940

Net Income

-$857,944

EPS (Diluted)

$-2.74

Cash Flow

Operating Cash Flow

-$722,451

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4M

Total Liabilities

$8,229

Stockholders' Equity

$4M

Cash & Equivalents

$154,791

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,681	-$5,500	-21.5%
Operating Income	-$861,940	-$1M	+30.2%
Net Income	-$857,944	-$1M	+30.1%